The Second Affiliated Hospital & Yuying Children's Hospital/The Second School of Medicine, Wenzhou Medical University, Wenzhou, China.
Department of Pathology, The 958th Hospital, Southwest Hospital, Army Medical University, Chongqing 400038, China.
Exp Cell Res. 2023 Jul 15;428(2):113651. doi: 10.1016/j.yexcr.2023.113651. Epub 2023 May 16.
Oncoprotein-induced transcript 3 (OIT3) facilitates macrophage M2 polarization and hepatocellular carcinoma (HCC) progression, however, whether OIT3 regulates tumor immunity remains largely unknown. Here we found that OIT3 was upregulated in HCC-associated macrophages, which inhibited CD4 and CD8 T-cell infiltration in the tumor microenvironment (TME). Mechanistically, OIT3 increased the expression of PD-L1 on tumor-associated macrophages (TAMs) by activating NF-κB signaling, blockade of NF-κB reversed the immunosuppressive activity of TAMs and dampens HCC tumorigenesis. Our findings provide the molecular basis for OIT3 enhancing tumor immunosuppression and highlighted a potential therapeutic strategy for targeting the TAMs of HCC.
癌蛋白诱导转录物 3(OIT3)促进巨噬细胞 M2 极化和肝细胞癌(HCC)进展,然而,OIT3 是否调节肿瘤免疫仍知之甚少。在这里,我们发现 OIT3 在 HCC 相关巨噬细胞中上调,抑制肿瘤微环境(TME)中 CD4 和 CD8 T 细胞的浸润。在机制上,OIT3 通过激活 NF-κB 信号增加肿瘤相关巨噬细胞(TAMs)中 PD-L1 的表达,阻断 NF-κB 逆转了 TAMs 的免疫抑制活性并抑制 HCC 肿瘤发生。我们的研究结果为 OIT3 增强肿瘤免疫抑制提供了分子基础,并强调了针对 HCC TAMs 的潜在治疗策略。